Indaptus Therapeutics Market Sentiment - Benzinga

Indaptus Therapeutics Inc

INDPNASDAQ

Trade with Public

Trade with Public

$1.16

가까이에: Aug 25, 5:00 PM EST

$1.16

N/A

시간외: 6:53 PM EST

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 주식 보고서

Indaptus Therapeutics Market Sentiment

Market sentiment signals for Indaptus Therapeutics (INDP): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 0.1% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

2 analysts

Options Flow (P/C)

—

Avg Consensus PT

$9

+632.8%

Highest Price Target

$12

+934.5%

HC Wainwright & Co.

Lowest Price Target

$5

+331.0%

Maxim Group

Short Interest

0.1%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Nov 13, 2024	Maxim Group	Jason McCarthy—	+331.0%	$8 → $5	Maintained	Buy
Oct 16, 2024	HC Wainwright & Co.	Raghuram Selvaraju—	+934.5%	$12 → $12	Maintained	Buy
Jun 17, 2024	HC Wainwright & Co.	Raghuram Selvaraju—	+934.5%	$12 → $12	Maintained	Buy
Apr 15, 2024	HC Wainwright & Co.	Raghuram Selvaraju—	+934.5%	$12 → $12	Maintained	Buy
Sep 20, 2023	HC Wainwright & Co.	Raghuram Selvaraju—	+934.5%	$12	Maintained	Buy

More with Benzinga EdgeGet Access

Insider & Market Activity News

PRO
Indaptus Entered Into $6M Securities Purchase Agreement With Investor David Lazar

Benzinga Newsdesk

Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading?

Indaptus Therapeutics surged 64.65% in after-hours trading following a major insider investment and board appointment.

Mohd Haider

Around $15M Bet On Taysha Gene Therapies? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones closed lower by around 180 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Chief Medical Officer at Indaptus Therapeutics Acquires Company Stock Options Worth 90,000 Shares

Benzinga Insights

Stocks That Hit 52-Week Lows On Thursday

On Thursday, 241 companies hit new 52-week lows.

Benzinga Insights

Stocks That Hit 52-Week Lows On Tuesday

During Tuesday's session, 454 stocks hit new 52-week lows.

Benzinga Insights